Made with ❤️ by True Sparrow

Bringing you the latest funding data

Cellugy

Last funding round

Raised
$5,300,000
Round
Seed

Funding News (1)

3 weeks agoTech.eu

Startup details

Cellugy

Cellugy

Cellugy is a Danish biotech startup that focuses on developing sustainable solutions for everyday products by producing high-performing dry cellulose to replace fossil-based petrochemical ingredients in personal care products.
www.cellugy.com
Denmark
Established in 2018
2-10 People
Industrials

Founders

Dr. Isabel Alvarez-Martos

Ex: Aarhus University, Universidad de Oviedo, Colorado State University

Copenhagen, Capital Region Of Denmark, Denmark

Investment details

Raised
$5,300,000
Round
Seed
Investors
ICIG Ventures
LEAD
Unusual Ventures
Export and Investment Fund
The Footprint Firm
PreSeed Ventures
Joyance Partners

Founder Stories

Dr. Sterghois Moschos, PulmoBioMed

Recent 5 from Denmark

Jun2024
1

5 days ago

Light raised a $13M Seed led by Atomico
Copenhagen-based Light reimagines general ledger software with AI for global companies.
Light

Founders

Filip Kozjak,

Jonathan Sanders

In News

TechCrunch
2

1 week ago

EvodiaBio raised $7.6M led by The March Group and 2 others
Denmark-based EvodiaBio applies precision fermentation technology to produce sustainable aromas for the F&B industry.
EvodiaBio

Founders

Simon Dusséaux,

Camilla Fenneberg,

Jarne Elleholm

In News

FoodBev Media
Tech Funding News
vegconomist - the vegan business magazine
3

1 week ago

GetWhy raised a $34.2M Series A from PeakSpan Capital
Copenhagen-based GetWhy provides AI-enabled consumer insights for brands, disrupting consumer research with its proprietary platform.
GetWhy

Founders

Casper Henningsen,

Jonas Alexandersson

In News

EU-Startups
TechCrunch
4

2 weeks ago

ZTLment raised a $2.6M Pre-Seed from Giant Ventures and 3 others
Copenhagen-based ZTLment revolutionizes European payments with compliant wallet infrastructure.
ZTLment

Founders

Mads Stolberg-Mathieu

In News

FinTech Global
5

2 weeks ago

Adcendo raised $17.2M led by Dawn Biopharma
Denmark-based Adcendo develops antibody-drug conjugates (ADCs) for cancer treatment.
Adcendo

Founders

Michael Pehl

In News

FinSMEs
Investors in Healthcare
Spot a snag? Report it.
raised@truesparrow.com
Made with ❤️ by True Sparrow
© 2024 True Sparrow Systems Pvt. Ltd. All rights reserved.